Verona Pharma PLC
NASDAQ:VRNA
Verona Pharma PLC
NASDAQ:VRNA
Price:
86
USD
Market Closed
Market Cap:
$7.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Verona Pharma PLC
NASDAQ:VRNA
|
UK |
|
Central Omega Resources Tbk PT
IDX:DKFT
|
ID |
|
S
|
Springer Nature AG & Co KgaA
F:SPG
|
DE |
|
Wells Fargo & Co
NYSE:WFC
|
US |
|
E
|
Eurofins Scientific SE
XHAM:ESF0
|
LU |
|
S
|
Seafco PCL
SET:SEAFCO
|
TH |
|
N
|
Naver Corp
OTC:NHNCF
|
KR |
|
Aptus Value Housing Finance India Ltd
NSE:APTUS
|
IN |
|
C
|
Caseys General Stores Inc
F:CS2
|
US |
|
K
|
Kforce Inc
XMUN:ROF
|
US |
|
Vision Marine Technologies Inc
XTSX:VMAR
|
CA |
|
Rinnai Corp
OTC:RINIF
|
JP |
|
O
|
Orion Oyj
XMUN:OFK
|
FI |
|
Befesa SA
OTC:BFSAF
|
LU |
|
Atlas Arteria Group
ASX:ALX
|
AU |
|
Amper SA
MAD:AMP
|
ES |
|
E
|
Edison International
SWB:EIX
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRNA's stock price target?
Not Available
VRNA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Verona Pharma PLC?
Projected CAGR
202%
202%
The compound annual growth rate for Revenue over the next 3 years is 202%.
